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The current study aims to identify a superior closure technique for 
the surgical treatment of hidradenitis suppurativa based on the 
most clinically significant complication rates. Excision of diseased 
hidradenitic tissue results in a soft tissue defect that must be 
closed using one of a variety of reconstructive options. Here, we 
consider the post-operative complication rates of three closure 
methods performed at Lehigh Valley Health Network—primary 
closure, local flap closure, and skin grafting—to both contribute 
to the body of literature on the topic and propose a best closure 
method. 
Hidradenitis suppurativa is a complicated, chronic inflammatory 
dermatologic condition characterized by comedone-like follicular 
inclusions. Although the exact underlying mechanism of disease 
is still disputed, leading theories suggest apocrine gland or 
pilosebaceous unit involvement. Clinically, the disease is manifest 
by the development of painful nodules, abscesses, sinus tracts, 
and hypertrophic scarring of the skin. Hidradenitis may occur 
anywhere on the body but is most common at the intertriginous 
zones of the axillary, inframammary, inguinal, and perineal skin. 
Risk factors for the development of hidradenitis include smoking, 
obesity, and female sex and there is a higher incidence in African 
Americans. 
Treatment of the disease is exceptionally challenging and consists 
of both non-surgical and surgical options. Conservative measures 
are generally indicated for earlier stage disease and consist of 
antibiotics, glucocorticoids, and retinoids, among others. Surgical 
intervention is indicated for severe or refractory disease and is 
the only definitive option for cure. When surgery is performed, 
the local excision of diseased tissue often results in a large, 
contaminated defect that requires closure and reconstruction to 
preserve both function and cosmesis. Reconstructive methods 
include closure by secondary intention, primary intention, skin 
grafting, and fasciocutaneous and myocutaneous flaps. The body 
of literature on the surgical treatment shows no consensus on 
a superior closure technique. The present study seeks to build 
upon this knowledgebase by considering three possible surgical 
reconstructive options and all of their significant complications. 
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Problem Statement
 
In total, 401 operative sites for 189 operations of 103 individual 
patients were reviewed. The average patient age was 35.0 years. 
At time of operation, 87 patients were current smokers, 18 had 
a remote smoking history, 33 had diabetes mellitus, and 34 had 
hypertension. There were 201 closures performed by primary 
closure technique, 193 by local flap, and 7 by skin grafting. There 
were no incidences of DVT, PE, or transfusion requirement for any 
patient. 
The sites closed by primary intention had rates of 27.36%, 
7.46%, and 30.85% for wound dehiscence, superficial surgical 
site infection (SSI), and total recurrence, respectively. Local flap 
closures had rates of 43.01%, 8.81%, and 36.27% for wound 
dehiscence, superficial SSI, and total recurrence, respectively. For 
the skin graft closures, only 1 site (14.29%) experienced wound 
dehiscence and 1 site superficial SSI. There were no episodes of 
recurrence for skin graft closures, but 3 sites experienced partial 
graft loss that required some healing by secondary intention. 
Partial graft loss was defined as 10-90% loss based on national 
complication database criteria. Table 1 below shows the collective 
findings for the recorded complications and Figure 1 depicts the 
three most prevalent complications.
Results
 
The aim of this project was to identify a superior closure technique 
based on post-operative complication rates for the three chief 
closure methods at Lehigh Valley Health Network. After the review 
of 401 operative sites for 103 patients, we have shown that skin 
grafting is superior to primary and flap closure in our patient 
population based on lower recurrence, wound dehiscence, and 
superficial SSI rates (Table 1). However, the small number of skin 
graft reconstruction cases was small compared to the two other 
methods. Our complication rate findings are consistent with other 
previous investigations10,11,18 and add to the body of evidence 
that suggests a shift in the surgical treatment paradigm in favor of 
skin grafting for severe and refractory hidradenitis.
Several limitations of this project presented themselves during the 
data collection and analysis process. As aforementioned, the review 
of each patient record required the assessment of three charts, 
including one paper chart and two electronic medical records. 
This introduced a significant challenge in collection of data points 
as relevant data was located in any or all of the record types. It 
also substantially prolonged the time required for collection. Next, 
determining whether or not a hidradenitis lesion represents residual 
or recurrent hidradenitis can be challenging for clinicians and some 
charts were not precise in stating whether or not a given lesion 
was residual, remaining diseased tissue from a prior incomplete 
excision, or recurrent, a true new lesion. The common waxing and 
waning course of hidradenitis further complicates this issue for 
clinicians. 
In addition to providing valuable treatment and outcomes data 
for the Lehigh Valley Health Network patient population, the data 
recorded in this study can also be used in the future for both 
academic and quality improvement purposes. Perhaps most evident 
is that the data reported above may now be compared to other 
similar studies in hidradenitis surgical outcomes research. Also, 
as mentioned above, the data serves as further evidence that skin 
grafting should be considered before primary and local flap closure, 
at least in consenting patients with appropriate wound bed. Tracking 
Operations and Outcomes for Plastic Surgeons (TOPS) is a national 
database program launched in 2002 by the American Society of 
Plastic Surgeons that strives to collect self-reported outcomes data 
as a practice management, research, and advocacy tool for the 
specialty and its patients. By submitting the data reported here to 
TOPS in the future, it could be compared to the national database’s 
outcomes for these procedures. Indeed, one of the goals of TOPS is 
to help physician leaders and plastic surgeons determine national 
benchmarks and practice patterns and our data could be a valuable 
piece of that process.
 
The data reported in this study show that superficial wound 
dehiscence, superficial SSI, and recurrence are the major post-
operative complications in patients that undergo surgical excision 
of hidradenitis with either primary or flap closure. Skin grafting 
for wound closure appears to have lower rates of these three 
complications, but the number of operative sites closed by this 
method in the studied patient population was small. These 
results further support the idea that skin grafting after excision of 
hidradenitis, at least for resultant wounds with appropriate wound 
beds, is superior to primary intention and local flap reconstruction 
methods. Future studies with a larger number of skin graft closure 
cases are required for validation of this study and to suggest a shift 
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A retrospective chart review of all patients who underwent 
surgical reconstruction for hidradenitis suppurativa at Lehigh 
Valley Health Network from January 1, 2004 to December 31, 
2014 was performed. First, all patient records with a diagnosis 
of “Hidradenitis Suppurativa” as identified by ICD-9 code 
705.83 were gathered within the EPIC electronic medical record 
database. To ensure only those patients who underwent surgical 
excision were included, the CPT codes 11451, 11450, 11462, 
11470, 11463, and 11471 were required to be listed in the 
chart. Patients were then stratified according to type of surgical 
reconstruction performed, including primary closure, skin graft, 
or local flap. Data was tabulated in a secure Microsoft Excel 
spreadsheet for simpler analysis.
 Patient charts were reviewed for documentation of all relevant 
complications for each individual operation and operative site: 
DVT, PE, seroma, hematoma, wound dehiscence, superficial 
surgical site infection (SSI), flap loss, graft loss, transfusion 
requirement, unplanned post-operative emergency department 
(ED) visit, unplanned post-operative hospital admission, 
unplanned post-operative return to the operating room (OR), and 
recurrence at the operative site within and after one year of the 
operation.
Methodology  
As the surgical treatment of hidradenitis continues to be 
investigated, the primary goal is to improve patient outcomes 
by having fewer complications. Indeed, this applies directly 
to the “Better Care” aspect of The Triple Aim, which we have 
studied directly within the Health Systems domain of the SELECT 
curriculum.  In general, complications of any surgical operation 
are financially taxing to the healthcare system and result in 
decreased value for patients over the course of their treatment. As 
hidradenitis may affect up to 4% of the population,2 determining 
a best practice closure method following excision can be of 
substantial savings to the health system—the “Better Cost” 
principle of The Triple Aim—even if surgical intervention is only 
reserved for those patients with later stage disease. A consensus 
within the plastic surgery field on superior method of closure has 
the potential to minimize all of the complications considered in the 
present study, resulting in the liberation of healthcare resources 
including time, personnel, and money for devotion to other 
endeavors.
Lastly, this project is directly relevant to patient-centered care. 
Presently, reconstructive options for patients following excision 
may be dependent on individual surgeon preference or institution 
policy. Subsequently, patients may not always be receiving the 
best evidence-based reconstructive options. By adding to the 
body of literature that suggests skin grafting is superior to other 
methods, the plastic surgery field may be one step closer to 
confirming this reconstruction method as the best choice for 
patient outcomes and surgeons will be able to offer patients 
choices with greater context.
SELECT Integration
Complication Primary Closure Local Flap Closure Skin Graft Closure
DVT 0% 0% 0%
Pulmonary Embolism 0% 0% 0%
Seroma 0% 0.52% 0%
Hematoma 1% 1.04% 0%
Superficial SSI 7.46% 8.81% 14.29%
Wound Dehiscence 27.36% 43.01% 14.29%
Partial Flap/Graft Loss N/A 1.55% 42.86%
Unplanned ED Visit 5.9% 7.25% 0%
Unplanned Return to OR 2.99% 2.59% 28.57%
Unplanned Hospital Admission 2.99% 4.15% 0%
Recurrence < 1 Year 18.91% 19.17% 0%
Recurrence > 1 Year 11.94% 17.10% 0%
Total Recurrence 30.85% 36.27% 0%
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Table 1.  30-day complication rates for all considered complications for primary, local flap, and 
skin graft closure.
Figure 1.  Complication rates of the three most prevalent complications for primary, local flap, 
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